CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 9.53: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.69%Below 5Y avg (1.02%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
38.7%Sustainable
Last Ex-Dividend
May 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.34BCNY498.51M · vs all stocks (USD)
Trailing P/E
55.24xvs Medical Devices peers
Revenue (TTM)
584.68MCNY87.25M · vs all stocks (USD)
Profit Margin
10.29%vs Medical Devices peers
Beta
0.0450xvs all stocks
52-Week Change
-16.85%vs all stocks
Market Capitalization
3.34BCNY498.51M · vs all stocks (USD)
Enterprise Value
2.73BCNY407.05M · vs all stocks (USD)
Trailing P/E
55.24xvs Medical Devices peers
Forward P/E
38.67xvs Medical Devices peers
Price to Sales (TTM)
5.71xvs Medical Devices peers
Price to Book (MRQ)
2.71xvs Medical Devices peers
Enterprise to Revenue
4.67xvs Medical Devices peers
Enterprise to EBITDA
36.93xvs Medical Devices peers
Gross Margin
50.63%vs Medical Devices peers
Profit Margin
10.29%vs Medical Devices peers
Operating Margin
9.98%vs Medical Devices peers
Return on Assets (TTM)
2.27%vs Medical Devices peers
Return on Equity (TTM)
4.95%vs Medical Devices peers
Revenue (TTM)
584.68MCNY87.25M · vs all stocks (USD)
Revenue per Share (TTM)
2.01CNYUpdated Sep 20, 2026Quarterly Revenue Growth
6.90%vs Medical Devices peers
Gross Profit (TTM)
289.56MCNY43.21M · vs all stocks (USD)
EBITDA (TTM)
72.63MCNY10.84M · vs all stocks (USD)
Net Income (TTM)
60.16MCNY8.98M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-50.00%vs Medical Devices peers
Operating Cash Flow (TTM)
96.85MCNY14.45M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.81MCNY-568.58K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0800CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.69%vs all stocks
5-Year Average Dividend Yield
1.02%vs all stocks
Payout Ratio
38.72%vs Medical Devices peers
Revenue
584.03MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
270.87MCNYFY2025 · Dec 31, 2025Gross Profit
313.16MCNYFY2025 · Dec 31, 2025Operating Income
81.47MCNY12.16M · vs all stocks (USD)
Pre-tax Income
98.66MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.60MCNYFY2025 · Dec 31, 2025Net Income
87.05MCNYFY2025 · Dec 31, 2025EBIT
99.09MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
126.29MCNYFY2025 · Dec 31, 2025Research & Development
60.43MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
92.06MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.31MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
428.89KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
290.18MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
290.18MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
87.05MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
51.81MCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
437.91MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
87.05MCNYFY2025 · Dec 31, 2025Other Non-cash Items
9.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-25.97MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.71MCNYFY2025 · Dec 31, 2025Capital Expenditures
-54.60MCNYFY2025 · Dec 31, 2025Sale of Investments
16.39MCNYFY2025 · Dec 31, 2025Other Investing Activity
88.68MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
50.47MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-25.06MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.44MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-28.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
288.00MSharesUpdated Sep 20, 2026Float Shares
95.66MSharesUpdated Sep 20, 2026% Held by Insiders
68.48%vs all stocks
% Held by Institutions
1.48%vs all stocks
Total Cash (MRQ)
617.51MCNY92.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.14CNYUpdated Sep 20, 2026Total Debt (MRQ)
4.55MCNY679.42K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0037xvs Medical Devices peers
Current Ratio (MRQ)
3.99xvs Medical Devices peers
Book Value per Share (MRQ)
4.28CNYUpdated Sep 20, 2026Total Assets
1.49BCNY222.60M · vs all stocks (USD)
Total Current Assets
934.68MCNYFY2025 · Dec 31, 2025Total Liabilities
258.79MCNYFY2025 · Dec 31, 2025Total Non-current Assets
557.09MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
6.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
251.82MCNYFY2025 · Dec 31, 2025Cash
437.89MCNYFY2025 · Dec 31, 2025Cash Equivalents
45.94MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
483.83MCNYFY2025 · Dec 31, 2025Other Short-term Investments
165.06MCNYFY2025 · Dec 31, 2025Accounts Receivable
43.98MCNYFY2025 · Dec 31, 2025Inventory
201.32MCNYFY2025 · Dec 31, 2025Accounts Payable
170.87MCNYFY2025 · Dec 31, 2025Short-term Debt
2.94MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.07MCNYFY2025 · Dec 31, 2025Long-term Debt
3.07MCNYFY2025 · Dec 31, 2025Common Stock (Book)
288.00MCNYFY2025 · Dec 31, 2025Retained Earnings
670.59MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.23BCNY183.98M · vs all stocks (USD)
52-Week Low
8.89CNYUpdated Sep 20, 202652-Week High
16.90CNYUpdated Sep 20, 202652-Week Change
-16.85%vs all stocks
Beta
0.0450xvs all stocks
50-Day MA
11.10CNYUpdated Sep 20, 2026200-Day MA
12.04CNYUpdated Sep 20, 2026Avg 10-Day Volume
6.43MSharesUpdated Sep 20, 2026Avg 30-Day Volume
11.91MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.2100CNYUpdated Sep 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 9.53: safe zoneNotable
Altman Z-Score: 9.53
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Qingdao Vland Biotech Inc.
Tier 1ProductionApproval-Gated PipelineFlow
Hinova Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pacific Biosciences of California, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Onconic Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Puma Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanhua Bio-Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Sinobioway Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Bioperfectus Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Arvinas Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
REA Group Limited
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityHigh Retained Earnings With Profitability And Equity
Moriya Transportation Engineering Inc.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityHigh Retained Earnings With Profitability And Equity
TV Tokyo Holdings Corporation
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityHigh Retained Earnings With Profitability And Equity